Genetic Therapy Inc. (GTI) announced Monday that itsunderwriting group, managed by Smith Barney, Harris Upham& Co. and Montgomery Securities, has exercised its option topurchase an additional 225,000 shares in connection with thepublic offering of 1.5 million shares of common stock at $10per share, which started trading Jan. 28. Including the optionsexercised, the company has 10.9 million shares of commonstock outstanding (roughly 12 million on a fully diluted basis).
Genetic Therapy, of Gaithersburg, Md., develops deliverysystems for human gene therapy for genetic and acquireddiseases. The stock (NASDAQ:GTII) closed unchanged Mondayat $12.25.
(c) 1997 American Health Consultants. All rights reserved.